Findings

What do systematic reviews say?

10 questions · 10 findings · 4 reviews · Urology

Sort:Best matchNewest Highest certainty Download CSV

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 3 · 30%Low 3 · 30%Moderate 3 · 30%High 1 · 10%

Combination therapy vs anticholinergics

QoL · men with lower urinary tract symptoms secondary to benign prostatic obstruction

1 finding from 1 review

Anticholinergics combined with alpha‐blockers for treating lower urinary tract symptoms related to benign prostatic… 2021 · Cochrane Headline outcomes only
no estimate extracted
1 study · 56 participants
Low

Combination therapy vs placebo

QoL · men with lower urinary tract symptoms secondary to benign prostatic obstruction

1 finding from 1 review

Anticholinergics combined with alpha‐blockers for treating lower urinary tract symptoms related to benign prostatic… 2021 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 991 participants
Very low

Combination therapy vs alpha‐blocker

QoL · men with lower urinary tract symptoms secondary to benign prostatic obstruction

1 finding from 1 review

Anticholinergics combined with alpha‐blockers for treating lower urinary tract symptoms related to benign prostatic… 2021 · Cochrane Headline outcomes only
no estimate extracted
15 studies · 2687 participants
Very low

Silodosin vs naftopidil

QoL

1 finding from 1 review

Silodosin for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia 2017 · Cochrane Headline outcomes only
no estimate extracted
5 studies · 652 participants
Low

Silodosin vs alfuzosin

QoL

1 finding from 1 review

Silodosin for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia 2017 · Cochrane Headline outcomes only
no estimate extracted
1 study · 60 participants
Moderate

Silodosin vs placebo

QoL

1 finding from 1 review

Silodosin for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia 2017 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 820 participants
Moderate

Silodosin vs tamsulosin

QoL

1 finding from 1 review

Silodosin for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia 2017 · Cochrane Headline outcomes only
no estimate extracted
10 studies · 1707 participants
Low

BTURP vs MTURP

Bother (HRQoLc at 12 months) · men with lower urinary tract symptoms secondary to benign prostatic obstruction

1 finding from 1 review

Bipolar versus monopolar transurethral resection of the prostate for lower urinary tract symptoms secondary to benign… 2019 · Cochrane Headline outcomes only
no estimate extracted
11 studies · 2004 participants
Moderate

Serenoa repens vs placebo or no intervention

QoL · men with lower urinary tract symptoms secondary to benign prostatic obstruction

Serenoa repens showed no clear difference in quality of lifeMeasured by IPSS‐QoL score (range 0 to 6) compared with placebo or no intervention (high certainty).

1 finding from 1 review

Serenoa repens for the treatment of lower urinary tract symptoms due to benign prostatic enlargement 2023 · Cochrane Headline outcomes only
no estimate extracted
5 studies · 1001 participants
High

Serenoa repens in combination with other phytotherapy vs placebo or no intervention

QoL · men with lower urinary tract symptoms secondary to benign prostatic obstruction

1 finding from 1 review

Serenoa repens for the treatment of lower urinary tract symptoms due to benign prostatic enlargement 2023 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 265 participants
Very low